Related Experiment Videos

Implication of superoxide radicals on ischemia-reperfusion-induced skeletal muscle injury in rats

S Kawasaki1, S Sugiyama, N Ishiguro

  • 1Department of Orthopedic Surgery, Faculty of Medicine, University of Nagoya, Japan.

Insights

Long-acting polyoxyethylene-modified superoxide dismutase (SOD-POE) protects skeletal muscle from ischemia-reperfusion injury by reducing lipid peroxidation. SOD-POE improved ATP recovery and prevented lipid peroxide increases post-reperfusion in rat models.

Area of Science:

  • Biomedical Science
  • Skeletal Muscle Physiology
  • Oxidative Stress Research

Background:

  • Ischemia-reperfusion injury (IRI) is a significant clinical challenge affecting skeletal muscle.
  • Superoxide radicals and lipid peroxidation are implicated in IRI pathogenesis.
  • Effective therapeutic strategies for mitigating IRI are needed.

Purpose of the Study:

  • To elucidate the mechanism of skeletal muscle IRI.
  • To evaluate the efficacy of long-acting polyoxyethylene-modified superoxide dismutase (SOD-POE) in a rat model.
  • To investigate the role of lipid peroxidation and xanthine oxidase in IRI.

Main Methods:

  • Male Lewis rats underwent controlled ischemia and reperfusion of the gastrocnemius muscle.
  • Tissue adenosine triphosphate (ATP) and lipid peroxide (LPO) levels were measured.
  • Xanthine oxidase activity was assessed.
  • The effects of SOD-POE administration were evaluated.

Main Results:

  • ATP levels significantly decreased during prolonged ischemia and showed limited recovery post-reperfusion.
  • Lipid peroxide levels increased significantly after reperfusion, particularly following extended ischemia.
  • SOD-POE administration improved ATP recovery and significantly reduced post-reperfusion LPO levels.
  • Xanthine oxidase activity increased during prolonged ischemia and reperfusion, but was not affected by SOD-POE.

Conclusions:

  • Lipid peroxidation, driven by superoxide radicals from xanthine oxidase, contributes to skeletal muscle IRI.
  • SOD-POE demonstrates potential as a therapeutic agent to mitigate IRI by inhibiting lipid peroxidation.
  • Further clinical investigation into SOD-POE for IRI treatment is warranted.

Related Concept Videos